CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-15 | Iwicki Mark T Director | Grant or award | +2,450 | 271,660 | ||
| 2025-06-15 | Iwicki Mark T Director | Grant or award · Stock Option (right to buy) | +5,450 | 5,450 | ||
| 2025-06-15 | Farid Marjan Director | Grant or award | +2,450 | 10,242 | ||
| 2025-06-15 | Farid Marjan Director | Grant or award · Stock Option (right to buy) | +5,450 | 5,450 | ||
| 2025-06-15 | PERRY GREGORY D Director | Grant or award | +2,450 | 13,344 | ||
| 2025-06-15 | PERRY GREGORY D Director | Grant or award · Stock Option (right to buy) | +5,450 | 5,450 | ||
| 2025-06-15 | Myers C. Daniel Director | Grant or award | +2,450 | 10,374 | ||
| 2025-06-15 | Myers C. Daniel Director | Grant or award · Stock Option (right to buy) | +5,450 | 5,450 | ||
| 2025-06-15 | KOVEN ANDREW I Director | Grant or award | +3,050 | 16,972 | ||
| 2025-06-15 | KOVEN ANDREW I Director | Grant or award · Stock Option (right to buy) | +6,850 | 6,850 | ||
| 2025-06-03 | Iwicki Mark T Director | Sale | −10,866 | $3.74 | $41K | 269,210 |
| 2025-06-03 | Kharabi Darius CHIEF BUSINESS OFFICER | Sale | −730 | $3.74 | $3K | 67,077 |
| 2025-06-03 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −2,850 | $3.74 | $11K | 65,731 |
| 2025-06-03 | Bazemore Todd SEE REMARKS | Sale | −3,390 | $3.74 | $13K | 87,757 |
| 2025-06-03 | Brazzell Romulus K SEE REMARKS | Sale | −3,687 | $3.74 | $14K | 87,949 |
| 2025-06-03 | Iwicki Mark T Director | Sale | +10,866 | $3.74 | $41K | 269,210 |
| 2025-03-07 | Bazemore Todd SEE REMARKS | Grant or award · Stock Option (right to buy) | +45,200 | 45,200 | ||
| 2025-01-06 | Kharabi Darius CHIEF BUSINESS OFFICER | Grant or award | +10,100 | 69,828 | ||
| 2025-01-06 | Kharabi Darius CHIEF BUSINESS OFFICER | Sale | −2,021 | $7.63 | $15K | 67,807 |
| 2025-01-06 | Kharabi Darius CHIEF BUSINESS OFFICER | Grant or award · Stock Option (right to buy) | +45,200 | 45,200 |
Page 2 of 12 · 236 trades